Search Results - "Brazert, J"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Maternal endothelial dysfunction and its association with abnormal fetal growth in diabetic pregnancy by Zawiejska, A., Wender-Ożegowska, E., Pietryga, M., Brązert, J.

    Published in Diabetic medicine (01-06-2011)
    “…Diabet. Med. 28, 692–698 (2011) Aims  Some authors consider the vascular endothelium to be a target organ in diabetes. However, there have only been a few…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Placental leptin and its receptor genes expression in pregnancies complicated by type 1 diabetes by Iciek, R, Wender-Ozegowska, E, Zawiejska, A, Mikolajczak, P, Mrozikiewicz, P M, Pietryga, M, Brazert, J

    “…Type 1 diabetes mellitus (T1DM) is still associated with increased risk for severe maternal and fetal complications but their pathomechanism remains unclear…”
    Get more information
    Journal Article
  7. 7

    Metabolic syndrome in type 1 diabetes mellitus. Does it have any impact on the course of pregnancy? by Wender-Ozegowska, E, Zawiejska, A, Michalowska-Wender, G, Iciek, R, Wender, M, Brazert, J

    “…To determine whether the symptoms of metabolic syndrome (MS), if accompanied by oxidative stress (OS), in type 1 diabetes mellitus (DM) patients could affect…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Placental vascular endothelial growth factor expression in pregnancies complicated by type 1 diabetes by Iciek, R, Wender-Ozegowska, E, Mikolajczak, P, Seremak-Mrozikiewicz, A, Zawiejska, A, Mrozikiewicz, P M, Drews, K, Brazert, J

    “…Type 1 diabetes mellitus (T1DM) is still associated with increased risk of severe maternal and foetal complications but their pathomechanism remains unclear…”
    Get more information
    Journal Article
  10. 10

    Components of metabolic syndrome and their impact on fetal growth in women with gestational diabetes mellitus by Zawiejska, A, Wender-Ozegowska, E, Brazert, J, Sodowski, K

    “…Gestational diabetes mellitus (GDM) is associated with increased maternal insulin resistance. Maternal hyperglycemia is a well known risk factor for fetal…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13

    Concentration of chemokines in peripheral blood in first trimester of diabetic pregnancy by Wender-Ozegowska, E, Michalowska-Wender, G, Zawiejska, A, Pietryga, M, Brazert, J, Wender, M

    “…Several types of regulators (i.e. chemokines and metalloproteinases) are considered to play a crucial role in pregnancy by local modulation of the immune…”
    Get more information
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Plasma anhydro-d-glucitol (1,5-AG) as an indicator of hyperglycaemic excursions in pregnant women with diabetes by Dworacka, M., Wender-Ożegowska, E., Winiarska, H., Borowska, M., Zawiejska, A., Pietryga, M., Brazert, J., Szczawinska, K., Bobkiewicz-Kozłowska, T.

    Published in Diabetic medicine (01-02-2006)
    “…Aims  To evaluate the use of the plasma 1,5‐anhydro‐d‐glucitol (1,5‐AG) level as a possible marker for glucose excursions in pregnant women with diabetes…”
    Get full text
    Journal Article
  20. 20

    Leptin gene, leptin gene polymorphisms and body weight in pregnant women with diabetes mellitus type I by Iciek, R, Wender-Ozegowska, E, Seremak-Mrozikiewicz, A, Drews, K, Sodowski, K, Pietryga, M, Brazert, J

    “…There have been several genetic causes of obesity discussed by past authors, among others leptin, that have provided information regarding signaling pathways…”
    Get more information
    Journal Article